Третий глаз. Обзор нашлемных систем целеуказания
Published • Sep 30, 2007
Authors:
Владимир Ткач
Abstract
Inhibition of glioblastoma growth and invasion can be achieved using i.c. delivery of an anti-EGFR antibody, but tumor response depends on the presence of amplified and/or mutated EGFR. Antiangiogenic treatment with DC101 is not effective against diffusely invading tumors.